Clinical Trial Update: Clinical Trial to Evaluate Efficacy and Safety of Acellbia® (JSC "BIOCAD") With Methotrexate in First Line Biological Therapy of Patients With Active Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Acellbia with methotrexate in first-line biological therapy for active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Acellbia (Acellbia)

Snippet

Sponsor: Biocad | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED